Jonathan Doose, Director at The Playbook, is a transformational biotech leader with a strong record of scaling early-stage and high-growth life sciences organizations. With deep expertise in customer development, go-to-market strategies, strategic partnerships, and commercialization of cutting-edge genomics and proteomics technologies, Jonathan excels at translating complex science into compelling business value for biopharma, CRO/CDMO, and academic markets.

Throughout his career, Jonathan has consistently delivered growth in highly competitive environments. At ArcherDX, he led the launch and commercialization of the company’s ctDNA targeted NGS platform for liquid biopsy research, expanding oncology market penetration. He also played a pivotal role in advancing clinical genomics adoption at institutions such as Mayo Clinic, Huntsman Cancer Institute, Intermountain Precision Genomics, and Phoenix Children’s Hospital.

Jonathan is known for building and empowering high-performing teams, influencing C-suite stakeholders, and aligning cross-functional groups around strategy and execution. His achievements include driving 200%+ year-over-year revenue growth through customer development and process optimization, securing multi-million-dollar partnerships, and achieving a 60% close rate on new opportunities.

As Director at The Playbook, Jonathan is committed to its collaborative mission: bridging science and strategy to accelerate innovation. He partners with biotech leaders to design sustainable revenue models, capture high-value markets, and ultimately improve patient outcomes through scientific innovation.